Shanghai Serum Bio-Technology Co., Ltd.SSE: 688163

Report for Q3 2024

Oct 26, 2024 · Issued by Shanghai Serum Bio-Technology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 26, 2024

On 6ix: 6ix.com/news/report-for-q3-2024-387

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Serum Bio-Technology Co., Ltd. on 6ix

Earlier from Shanghai Serum Bio-Technology

Announcement on Convening Q3 2024 Performance BriefingOct 22, 2024
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024Oct 1, 2024
Announcement on Convening 2024 Semi-annual Performance and Cash Dividend BriefingSep 19, 2024
Notice on Convening the 1st Extraordinary General Meeting in 2024Sep 14, 2024
Announcement on Implementation of Dividend Distribution for Half Year of 2024Sep 6, 2024

Later from Shanghai Serum Bio-Technology

Announcement on Provision for Impairment of Long-term Equity InvestmentNov 23, 2024
Announcement on Change of Chief Financial OfficerFeb 8, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 26, 2025
Announcement on Using Some Temporarily Idle Raised Funds for Cash ManagementMar 21, 2025
Announcement on Changing Project Quality Control Reviewer of Audit InstitutionApr 9, 2025

All Shanghai Serum Bio-Technology news releases

Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.

Follow Shanghai Serum Bio-Technology